Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-11

Clinical Trial Update: A Phase II, Safety and Efficacy Study of Inactivated EV 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants [Phase 2]

View source ↗

Summary

Phase II trial assessing safety and efficacy of an inactivated EV71 vaccine (Human Diploid Cell, KMB-17) in Chinese infants/children for hand, foot and mouth di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inactivated EV71 Vaccine (Human Diploid Cell, KMB-17) (EV71 vaccine)

Snippet

Sponsor: Institute of Medical Biology, Chinese Academy of Medical Sciences | Conditions: The Study Focused on the Safety of Inactivated EV71 Vaccine (Human Diploid Cell) Against Hand, Foot and Mouth Disease in Chinese Children and Infants | Phase 2 | Status: COMPLETED